Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system

US6194428A · kind A · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Klaus Urbahns · Kasai, JP
• Hans-Georg Heine · Krefeld, DE
• Bodo Junge · Wuppertal, DE
• Rudolf Schohe-Loop · Wuppertal, DE
• Henning Sommermeyer · Neunburg vorm Wald, DE
• Thomas Glaser · Overath, DE
• Reilinde Wittka · Neunburg vorm Wald, DE
• Jean De Vry · Stolberg, DE

Key dates

• Filing date: Jan 28, 1999
• Grant date: Feb 27, 2001
• Expiry date: Jan 28, 2019

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of 5-substituted pyridine- and hexahydroquinoline-3-carboxylic acid derivatives, some of which are known, for the production of medicaments, in particular for the treatment of cerebral disorders.